The global population at risk from mosquito-borne diseases—including dengue, yellow fever,
chikungunya and Zika—is expanding in concert with changes in the distribution of two key …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel member of the
Coronaviridae family, has been identified as the etiologic agent of an ongoing pandemic of …

Recently, the Vaccines to Vaccinate (v2V) initiative was reconfigured into the Partnership for
Dengue Control (PDC), a multi-sponsored and independent initiative. This redirection is …

As the coronavirus disease 2019 (COVID-19) pandemic progresses, social distancing has
emerged as an effective measure to restrain the spread of infections. Many people are now …

Populations on the edge of an expanding range are subject to unique evolutionary pressures
acting on their life‐history and dispersal traits. Empirical evidence and theory suggest that …

Mathematical models of mosquito-borne pathogen transmission originated in the early twentieth
century to provide insights into how to most effectively combat malaria. The foundations …

Background Dengue has been a notifiable disease in China since 1 September 1989.
Cases have been reported each year during the past 25 years of dramatic socio-economic …

The COVID-19 pandemic has forced societies across the world to resort to social distancing
to slow the spread of the SARS-CoV-2 virus. Due to the economic impacts of social …

Background Major gains have been made in reducing malaria transmission in many parts of
the world, principally by scaling-up coverage with long-lasting insecticidal nets and indoor …

Background Large Phase III trials across Asia and Latin America have recently demonstrated
the efficacy of a recombinant, live-attenuated dengue vaccine (Dengvaxia) over the first 25 …